Plastid transformation

Abstract

The present invention relates to the field of plastid transformation. The invention provides transformation vectors and methods to obtain transplastomic plants or algae having a transformed plastid comprising the steps of introducing into plastids a recombinant nucleic acid molecule or vector, and two phases of selection with first selection phase using a non-lethal compound and a second selection phase using a lethal compound . Alternatively, the dual selection method is conducted simultaneously using a lower concentration of the lethal compound.

Description

FIELD OF THE INVENTION

[0002] The present invention relates to the field of plastid transformation. The invention provides transformation vectors and methods to obtain transplastomic plants or or algae having a transformed plastid comprising the steps of introducing into plastids a recombinant nucleic acid molecule or vector, and two phases of selection with first selection phase using a non-lethal compound and a second selection phase using a lethal compound. Alternatively, the dual selection method is conducted simultaneously, using a lower concentration of the lethal compound.

BACKGROUND OF THE INVENTION

[0003] Improvement of plant varieties through transformation has become increasingly important for modern plant breeding. Various gene transfer technologies allow the incorporation of foreign DNA molecules into plants genomes. The expression of genes encoded by such foreign DNA molecules (transgenes, genes of interest) can potentially confer new beneficial characteristics to the plant like, for example, improved crop quality or yield. The expression of transgenes can also allow for the use of plants as bioorganic factories.

[0004] Most gene transfer systems, such as Agrobacterium-mediated transformation or bombardment with DNA-coated particles, stably integrate heterologous genes in the nuclear genome of the plant by means of non-homologous recombination. Plant engineering using these methods has several drawbacks. These methods produce a population of transformants varying in their transgene copy number and whose expression is often unpredictable because of position effect variations or possible gene silencing. Most transgenic plants produced by these methods contains within their nuclear genome non-desired vector sequences associated with the gene of interest. Furthermore, the threat of transgene contamination of wild relative plants from genetically modified plant is a major environmental concern. The risk of transgene escape from genetically altered crops to wild relatives predominantly arises through pollen dissemination.

[0005] Plastid gene transformation is an important alternative for the expression of heterologous genes in plants (reviewed by Bogorad, Trends Biotechnol. 18: 257-263, 2000 and Bock, J. Mol. Biol. 312: 425-438, 2001). Although plastid genomes are relatively small in size, 120 to 160 kb, they can easily accommodate several kilo bases of foreign DNA within them. Insertion of foreign DNA in the plastid genome mainly occurs via homologous recombination and a transgene can be site directed at a particular locus using suitable homologous flanking regions. One of the major advantages of plastid transformation is that it is possible to obtain very high transgene expression. The plastid genome (plastome) is highly polyploid so the transgene is expressed from multiple gene copies in the plastid. The polyploidy of the plastid genome is such that a mature leaf cell may contain over 10,000 copies of the plastome. Also contributing to the high level of the plastid transgene expression is absence of position effect and gene silencing. Another major advantage is that plastids from most crop plants are only maternally inherited and thus, the ecological risk of plastid transgene escape through pollen-mediated out crossing is minimized. The basic DNA delivery techniques for plastid transformation are either via particle bombardment of leaves or polyethylene glycol mediated DNA uptake in protoplasts. Plastid transformation via biolistics was initially achieved in the unicellular green alga Chlamydomonas reinhardtii (Boynton et al., Science 240: 1534-1537, 1988) and this approach, using selection for cis-acting antibiotic resistance loci (spectinomycin/streptomycin resistance) or complementation of non-photosynthetic mutant phenotypes, was extended to Nicotiana tabacum (Svab et al., Proc. Natl. Acad. Sci. USA 87: 8526-8530, 1990), Arabidopsis (Sikdar et al., Plant Cell Reports 18:20-24, 1991), Brassica napus (WO 00/39313), potato (Sidorov et al., The Plant Journal 19(2):209-216, 1999), petunia (WO 00/28014),tomato (Ruf et al., Nature Biotechnology 19: 870-875, 2001), oilseed rape (Hou et al., Transgenic Res. 12: 111-114, 2003) and Lesquerella Fendleri(Skaijinskaia et al., Transgenic Res. 12: 115-122, 2003). Plastid transformation of protoplasts from tobacco and the moss Physcomitrella patens has been attained using polyethylene glycol (PEG) mediated DNA uptake (O'Neill et al., Plant J. 3: 729-738, 1993; Koop et al., Planta 199: 193-201, 1996). More recently, micro-injection of DNA directly in plastids of marginal mesophyll cells of intact tobacco plant resulted in transient expression (Knoblauch et al., Nature Biotechnology 17: 906-909, 1999) but stable transformants using this technique have yet to be reported. Stable chloroplast transformation by biolistics was also reported for the Euglenophyte Eugena gracilis (Doetsch et al., Curr Genet. 39:49-60, 2001) and the unicellular red alga Porphyridium sp. (Lapidot et al., Plant Physiol. 129: 7-12, 2002), the dominant selectable marker used for latter consist of a mutant form of the gene encoding acetohydroxyacid synthase which confers tolerance to the herbicide sulfometuron methyl. As previously mentioned, chloroplast transformation consists of integrating a foreign DNA at a precise position in the plastid genome by homologous recombination. The plastid transformation vectors consist of cloned plastid DNA, homologous to the targeted region, which flanks a selectable marker gene which itself is linked to a gene or several genes of interest. After transformation, the transgene(s) and the selectable marker are inserted together as a block of heterologous sequence in the targeted locus of the plastid genome via homologous recombination between the vectors plastid sequence and the targeted locus. In order to obtain stably transformed homoplasmic plants, i.e. plants having the foreign DNA inserted into every plastome copy of the plant cell, several rounds of subculture on selective media are required. This process facilitates the segregation of transplastomic and untransformed plastids and results in the selection of homoplasmic cells with gene(s) of interest and the selectable marker stably integrated into the plastome, since these genes are linked together.

[0006] Most stable plastid transformation demonstrated to date has been based on selection using the antibiotic resistance gene aadA (as referenced above) or NPTII (Carrer et al., Mol Gen Genet 241:49-56, 1993), to obtain homoplasmic plants. These selectable markers confer a specific selection phenotype, the green pigmentation (U.S. Pat. No. 5,451,513), which allows to visually distinguish the green pigmented transplastomic cells from cells having wild-type plastids which are non pigmented under selection conditions.

[0007] Most plastid transformation methods rely on the use of a selectable marker that confers a non-lethal selection. These selectable markers also confer a specific selection phenotype, the green pigmentation (U.S. Pat. No. 5,451,513) which allows one to visually distinguish the green pigmented transplastomic cells from cells having wild-type plastids that are non-pigmented under selection conditions. For example, plants transformed with the bacterial aadA gene which confers resistance to spectinomycin and streptomycin grow normally in the presence of either one of these antibiotics whereas untransformed plants are bleached. Transformed plants can thus easily be identified using chlorophyll as a visual marker. There is a limited number of selectable markers available for plastid transformation and the most reliable ones, such as aadA or point mutations in the plastid 16S rDNA and rps12 genes, confer resistance to the same antibiotics, spectinomycin and/or streptomycin. Selectable markers conferring resistance to other antibiotics such as kanamycin were shown to be much less effective for plastid transformation.

[0008] There have been concerns on the antibiotic resistance genes in genetically modified (GM) crops because of the potential risks of horizontal gene transfer to micro organisms in the environment or to gut microbes. These potential risks may pose even greater concerns with transplastomic plants because of the prokaryotic characteristics of the plastid genome and the by far larger copy number of the transgene per cell. It is therefore highly desirable to obtain transplastomic plants without antibiotic resistance genes.

[0009] Another alternative are methods wherein the antibiotic resistance gene is removed after the transformation. Once plants are homoplasmic for the transgene, the presence of the selectable marker gene in the plastome is no longer required. Removal of the selectable marker from a transplastomic plant has been achieved by two different methods. The first method, initially developed for recycling of the selectable marker from a transformed C. reinhardtii plastome (Fischer et al., Mol. Gen. Genet. 251:373-80, 1996) and recently extended to Nicotiana tabacum (Iamtham and Day, Nat. Biotechnol. 18: 1172-1176, 2000), relies on the plastid homologous recombination system to delete the marker gene from the plastid genome. Homologous recombination between direct repeated sequences flanking the selectable marker results in the deletion of the DNA segment. This method requires several rounds of self- or backcrossing before transgenic plants without the selectable marker are obtained. The second method uses the Cre/lox recombination system (Hajdukiewicz et al., The Plant J. 27: 161-170, 2001; Corneille et al., The Plant J. 27: 171-179,2001) to excise the DNA segment. In this method the Cre-protein mediates the excision of a DNA segment located between two lox sites in direct repeat orientation. In order to remove the selectable marker, the Cre gene is introduced into the nuclei of the transplastomic plants either through nuclear transformation or through crossing. Once the selectable marker gene is removed, the Cre gene is eliminated by genetic crossing. Albeit successful, removal of the selectable marker using either one of these methods have some disadvantages. Both methods are lengthy processes as multiple rounds of crossing may be required, and both methods leave an undesired residual heterologous DNA segment in the plastid genome that serves no purpose. Furthermore, unspecific recombination causing DNA deletions was observed with Cre/lox recombination system (Hajdukiewicz et al., 2001). Thus, there is a need to develop other methods to obtain transplastomic plants without the stable integration of an antibiotic selectable marker in the plastid genome.

[0010] The application of antibiotic resistance genes as the selectable marker for plastid transformation is also limited by the requirement of the green pigmentation as the selection phenotype. A selection based on green pigmentation needs to be carried out in the light, which may not be the optimal culture condition for some plant cell cultures. Furthermore, not all the tissue types exhibit the green pigmentation phenotype under normal culture conditions, such as most of the cell cultures from cereal crops. It is therefore desirable to develop a selection strategy for plastid transformation in which the selection is not dependent on the green pigmentation.

[0011] Certain non-antibiotic resistance marker genes, such as the protoporphyrinogen oxidase gene (U.S. Pat. No. 6,084,155), 5-enolpyruvylshikimate-3-phosphate synthase genes (Daniell et al., Nature Biotech 16:345-348, 1998; Ye et al., The Plant Journal 25(3):261-270, 2001), and the bar gene (Lutz et al., Plant Physiology 125:1585-1590, 2001), can be effectively expressed in transplastomic plants. Most recently, EPSPS and bar gene are also reported being used in segregation approach to obtain herbicide resistant transplastomic plants with exclusion of antibiotic gene (Ye et al., Plant Physiology 133:402-410, 2003).

[0012] Another alternative is using the spinach betaine aldehyde dehydrogenase as the selectable marker that confers resistance to the lethal compound betaine aldehyde (Daniell et al., Curr Genet 2001 39:109-116, 2001).The present invention provides methods for plastid transformation in a wide variety of plant species and algae. It addresses the problem of removal of the antibiotic resistance marker which is delivered to the plastids during transformation and provides selection methods for homoplasmic transplastomic plants wherein green pigmentation of the selected phenotype is not a prerequisite.

SUMMARY OF THE INVENTION

[0013] One embodiment of the invention is a method for obtaining a transplastomic plant comprising the steps of: A method for obtaining a transplastomic plant comprising the steps of:

[0014] a) introducing into a plant cell plastid a recombinant nucleic acid molecule comprising two distinct selectable marker constructs, wherein the first marker confers resistance to a non-lethal selective compound (non-lethal marker) and the second marker confers tolerance to a lethal compound (lethal marker) and wherein each of the selectable marker constructs comprises a promoter functional in a plant cell plastid and a transcriptional termination region functional in a plant cell plastid

[0015] b) placing the plant cell comprising the recombinant nucleic acid molecule on a first culture medium comprising a plastid non-lethal compound for either 1) a period of about 2 weeks or 2) or until shoots appear on a callus formed from the plant cell;

[0016] c) placing the plant cell on a second culture medium comprising a plastid lethal compound for a period of time sufficient to permit the plant cell to be homoplasmic for the transgene.

[0017] In another embodiment, the method further comprises the step of: d) obtaining a transplastomic plant comprising only the second, lethal marker.

[0018] The method of claim 1, wherein the recombinant nucleic acid molecule further comprises one or more constructs of gene products of interest expressible in plastids are adjacent to the lethal marker.

[0019] In another embodiment the lethal marker and the gene construct are organized as a operon-like polycistronic gene.

[0020] In a preferred embodiment of the invention the introduction of the recombinant nucleic acid molecule is accomplished by a plastid transformation vector, said vector comprising the recombinant nucleic acid molecule encoding the non-lethal marker in its backbone sequence and the nucleic acid molecule encoding the lethal marker flanked by nucleic acid sequences which are homologous to non-essential plastid nucleic acid sequences.

[0021] In another preferred embodiment of the invention the delivery of the recombinant nucleic acid molecule encoding the markers is accomplished by a plastid transformation vector, said vector comprising the recombinant nucleic acid molecule encoding the non-lethal marker flanked by DNA sequences which are homologous to essential plastid DNA sequences and the nucleic acid molecule encoding the lethal marker flanked by nucleic acid sequences which are homologous to non-essential plastid nucleic acid sequences.

[0022] In another preferred embodiment the vector is transiently integrated into the plastome.

[0023] In another preferred embodiment a nucleic acid molecule encoding the non-lethal marker is unstably integrated into the plastome.

[0024] In another embodiment, the selected phenotype does not depend on the green pigmentation of the plastids.

[0025] In a preferred embodiment of the invention, the non-lethal marker is an antibiotic resistance gene. More preferably, the antibiotic resistance gene is aadA and the non-lethal selective compound is spectinomycin.

[0026] In another preferred embodiment of the invention, the lethal marker is a herbicide tolerance gene. More preferably, the herbicide tolerance gene is a mutated form of a protoporphorynogen oxidase (PPO) and the lethal selective compound is butafenacil or Formula XVII.

[0027] In a more preferred embodiment of the invention a plastid transformation vector comprises SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO: 19.

[0028] In another embodiment, the invention is a plastid transformation vector comprising a non-lethal marker flanked by sequences homologous to essential plastid DNA sequences but no non-lethal marker flanked by DNA sequences homologous to nonessential plastid DNA sequences. Preferably, the plastid transformation vector comprises SEQ ID NO:3.

[0029] In preferred embodiments of the invention the transformed plant cell or plant derived therefrom is tobacco, tomato, potato, brassica spp., safflower or lemna.

[0030] Another embodiment of the invention is a plastid transformation vector comprising a non-lethal marker in the backbone sequence of the vector and a lethal marker flanked by sequences which are homologous to non-essential plastid DNA sequences.

[0031] A preferred embodiment of the invention is a plastid transformation vector comprising SEQ ID NO: 1 or SEQ ID NO:2.

[0032] Another embodiment of the invention is a method of producing a homoplasmic transplastomic plant comprising:

[0033] a) delivery of a DNA fragment encoding at least two distinct selectable markers to plant plastids and expression of said markers in the plant plastids, wherein the first marker is conferring resistance to a non-lethal selective compound (non-lethal marker) and the second marker is conferring tolerance to a lethal compound (lethal marker),

[0034] b) a first round of selection using the non-lethal selective compound alone or in combination with the lethal selective compound for selection of transplastomic events,

[0035] c) a second round of selection using the lethal compound as the sole selective compound such that the non-lethal marker gene is removed from the plastome, and

[0036] d) selection of homoplasmic transplastomic events using the lethal compound as the sole selective compound, wherein the selected events have the lethal marker but not the non-lethal marker integrated into their plastome.

[0037] The method may further comprise the step of E) obtaining a transplastomic plant comprising only the lethal marker.

[0038] Another embodiment of the invention is a homoplasmic transplastomic plant produced by a this method.

[0039] A method for obtaining a chloroplast transformed algae comprising the steps of:

[0040] a) introducing into a plastid of a an algae a recombinant nucleic acid molecule encoding at least two distinct selectable markers expressible in plastids, wherein the first marker confers resistance to a non-lethal selective compound (non-lethal marker) and the second marker is conferring tolerance to a lethal compound (lethal marker) and wherein;

[0041] b) a first round of selection using the non-lethal selective compound alone or in combination with the lethal selective compound for selection of a transformed plastid; and

[0042] c) a second round of selection using the lethal compound as the sole selective compound such that the non-lethal marker gene is removed from the plastome.

[0043] Preferably, the algae is a Chlamydomonas spp., a red algae or a green algae.

[0044] The invention relates to a method of obtaining a transplastomic plant comprising the steps of

[0045] a) introducing into a plant cell plastid a recombinant nucleic acid molecule comprising two distinct selectable marker constructs, wherein the first marker confers resistance to a non-lethal selective compound (non-lethal marker) and the second marker confers tolerance to a lethal compound (lethal marker) and wherein each of the selectable marker constructs comprises a promoter functional in a plant cell plastid and a transcriptional termination region functional in a plant cell plastid

[0046] b) placing the plant cell comprising the recombinant nucleic acid molecule on a first culture medium comprising a plastid non-lethal compound and a lethal compound for 1) a period of about 2 weeks or 2) until shoots appear on a callus formed from the plant cell;

[0047] c) placing the plant cell on a second culture medium comprising a plastid lethal compound for a period of time sufficient to permit the plant cell to be homoplasmic for the transgene.

[0048] Preferably, wherein the lethal compound is a herbicide and the non-lethal compound is an antibiotic.

[0049] More preferably, wherein the lethal compound is butafenacil or Formula XVII and the antibiotic is spectinomycin or streptomycin.

[0050] The method of claim 33, wherein the concentration of the lethal compound is less than about 10 nM or wherein the concentration of the lethal compound is between about 5 nM and about 25 nM; or wherein the concentration of the lethal compound is between about 25 nM and about 50 nM.

BRIEF DESCRIPTION OF FIGURES

[0051] FIG. 1: Map of the pEBPPOt plastid transformation vector (SEQ ID NO:1). Plastid targeting sequence plDNA 16rDNA and rps12/7 are represented by hatched lines. Components of the chimeric A. thaliana ppo gene are the maize plastid 16S PEP-NEP rRNA gene promoter fused to the N. tabacum plastid rbcL RBS (SEQ ID NO:4; PmrrN), the A. thaliana ppo gene (Atppo) and the N. tabacum plastid rps16 3′UTR (3′rps16). Components of the chimeric aadA gene are N. tabacum psbA promoter (PpsbA) fused to aadA, aadA coding sequence (aadA) and the A. thaliana psbA 3′UTR (3′psbA). The ampicilline resistance on the vector backbone sequence (amp) is encoded by the bla gene and indicated by an arrow. The restriction sites are marked for: PstI, NdeI, EcoRI, EcoRV, BamHI and ScaI.

[0052] FIG. 2: Map of the pEB8 plastid transformation vector (SEQ ID NO:2). Plastid targeting sequence plDNA 16rDNA and rps12/7 are represented by hatched lines. Components of the chimeric A. thaliana ppo gene are N. tabacum psbA promoter (PpsbA), the A. thaliana ppo gene (Atppo) and the N. tabacum plastid rps16 3′UTR (3′rps16). Components of the chimeric aadA gene are the N. tabacum clpP plastid promoter (PclpP), the aadA coding sequence (aadA) and the N. tabacum plastid rps16 3′UTR (3′rps16). The ampicilline resistance gene on the vector backbone sequence (amp) is encoded by the bla gene and indicated by an arrow. The restriction sites are marked for: PstI, NdeI, EcoRI, EcoRV, BamHI and ScaI.

[0053] FIG. 3: Map of the pNY2C plastid transformation vector (SEQ ID NO:3). The plastid targeting sequences 1 (accession number NC—001879 position 96811 to 97844), 2 (position 95356 to 96811) and 3 (position 93132 to 95351) for homologous recombination are underlined. The chimeric aadA gene is inserted within the ycf2 essential gene at position 95351 of the tobacco plastid genome. The chimeric A. thaliana ppo gene is inserted into the intergenic region between plastid genes ndhB and trnL at position 96811 of the tobacco plastid genome. Components of the chimeric A. thaliana ppo gene are the maize plastid 16S PEP-NEP rRNA gene promoter fused to the N. tabacum plastid rbcL RBS (PmrrN), the A. thaliana ppo gene (Atppo) and the N. tabacum plastid rps16 3′UTR (3′rps16). Components of the chimeric aadA gene are N. tabacum psbA promoter (PpsbA) fused to aadA, aadA coding sequence (aadA) and the A. thaliana psbA 3′UTR (3′psbA). The restriction sites marked for: EcoRI, EcoRV, MluI, NcoI, NdeI, NgoMIV, ScaI, SnaBI, SpeI, XbaI and XhoI.

[0054] FIG. 4. illustrates a scheme for integration of PPO transgene into a plastid genome. Upon initial spectinomycin selection, the complete vector integrates the plastid genome via two possible recombination events occurring between the vectors chloroplast rps12 (1) or trnV-rrn 16 flanking sequences (2) and the plastid targeted locus. These single crossovers events creates a mix population of plastid transformed genomes having the vector inserted in different conformation. Subsequent, butafenacil selection allows second recombination event between direct repeated sequences that results in stable integration of the PPO gene in the plastid genome and complete excision of aadA with the vectors backbone sequence. Only one of two possible intra-recombination events is shown in the present example. Continuing butafenacil selection allows homoplasmic sorting for plastid genomes containing the PPO gene.

[0055] FIG. 5. Examples of Southern hybridization analysis to identify homoplasmic plastid transformants. A) BamHI length polymorphisms expected between wild type transformation locus, PPO transformed plastids and complete vector integration after single cross-over recombination event between the rps12 flanking sequences (1) or the trnV-rrn16 flanking sequences (2). B indicates position of BamHI restriction sites. B) Upper panel; Southern hybridization hybridization of BamHI digested total DNA from wild type (lane wt) and 10 transformants (lanes marked 1 to 10) and hybridized with probe specific to insertion locus. Wild type plastid sequence is observed at 3.2 kb, homoplasmic PPO transformed lines (lanes 1-3, 5-7 and 10) sequence at 5.0 kb. Heteroplasmic line (lanes 4 and 9) contain both PPO insert and wild type sequences. Lower panel; Southern hybridization hybridization of SpeI digested total DNA from wild type (lane wt) and 10 transformants (lanes marked 1 to 10) and hybridized with aadA gene specific probe. The aadA gene (0.9kb) is only observed in the heteroplasmic lines (lanes 4 and 9).

[0056] FIG. 6. Illustrates a scheme for integration of PPO transgene into plastid genome. Upon initial spectinomycin selection, selectable markers integrate the plastid genome via 3 possible double crossover recombination events occurring between the plastid transformation vector and the targeted plastid locus. Creating a mix population of plastid transformed genomes having either one or both selectable markers. Subsequent, butafenacil selection allows homoplasmic sorting for plastid genomes containing the PPO gene and complete excision of aadA from the essential gene.

[0057] FIG. 7. Map of the pEB10 plastid transformation vector. Plastid targeting sequence plDNA 16rDNA and rps12/7 are represented by hatched lines. Components of the chimeric A. thaliana ppo gene are the Staphylococcus aureus bacteriophages X2 promoter like-sequences fused to the bacteriophage kvp1 gene 10 5′UTR (PX2k10), the A. thaliana ppo gene (Atppo) and the N. tabacum plastid rps16 3′UTR (3′rps16). Components of the chimeric aadA gene are the N. tabacum clpP plastid promoter (PclpP), the aadA coding sequence (aadA) and the N. tabacum plastid rps16 3′UTR (3′rps16). The vectors ampicilline resistance gene (amp) is indicated by arrow. The restriction sites marked for are PstI, NdeI, EcoRI, EcoRV, BamHI and ScaI.

DESCRIPTION OF SEQUENCE LISTING

[0058] SEQ ID NO:1 pEBPPOt plastid transformation vector (Example 1 VII).

[0059] SEQ ID NO:2 pEB8 (=pEB8a) plastid transformation vector (Example 2).

[0060] SEQ ID NO:3 pNY2C plastid transformation vector (Example 4 II).

[0061] SEQ ID NO:4 DNA sequence of the maize plastid 16S PEP-NEP rRNA gene promoter fused to the N. tabacum plastid rbcL ribosome binding site (RBS).

[0062] SEQ ID NO:5 Top primer for amplification of the 16S PEP-NEP rRNA gene promoter from maize plastid DNA, the primer comprising an EcoRI restriction site (Example 1 I).

[0063] SEQ ID NO:6 Bottom primer comprising a BspHI restriction site (Example 1 I).

[0064] SEQ ID NO:7 Top primer for amplification of the A. thaliana ppo gene (Example 1 II).

[0065] SEQ ID NO:8 Bottom primer for amplification of the A. thaliana ppo gene, the primer comprising a SpeI restriction site (Example 1 II).

[0066] SEQ ID NO:9 Top strand primer for amplification of the N. tabacum psbA gene promoter, the primer comprising an EcoRI restriction site (Example 1 III).

[0067] SEQ ID NO:10 Bottom strand primer for amplification of the N. tabacum psbA gene promoter, the primer comprising a NcoI restriction site (Example 1 III).

[0068] SEQ ID NO:11 Top primer for amplification of the A. thaliana clpP gene promoter, the primer comprising an EcoRI restriction site (Example 1 V).

[0069] SEQ ID NO:12 Bottom primer for amplification of the A. thaliana clpP gene promoter, the primer comprising a BspHI restriction site (Example 1 V).

[0070] SEQ ID NO:13 Top primer for amplification of a new plastid DNA target locus, the primer comprising an XhoI restriction site (Example 4 I).

[0071] comprising an XhoI restriction site (Example 4 I).

[0072] SEQ ID NO:14 Bottom primer for amplification of a new plastid DNA target locus, the primer comprising an XbaI restriction site (Example 4 I).

[0073] SEQ ID NO:15 Staphylococcus aureau bacteriophage X2 promoter

[0074] SEQ ID NO:16 Kluyvera Bacteriophage kvp1 gen 10 5′ UTR

[0075] SEQ ID NO:17 Bacteriophage T3 gene 9 3′UTR

[0076] SEQ ID NO:18 Nucleotide sequence of chimeric Staphylococcus bacteriophage X2 promoter-like sequence fused to the bacteriophage kvp1 gene 10 5′ UTR.

[0077] SEQ ID NO:19 Nucleotide sequence of plastid transformation vector pEB10

[0078] SEQ ID NO:20 Top strand primer to amplify maize 16S NEP-PEP promoter (EcoRI site)

[0079] SEQ ID NO:21 Bottom strand primer to amplify maize 16S NEP-PEP promoter (XbaI site)

[0080] SEQ ID NO:22 Top strand primer to amplify bacteriophage T3 gene 5′UTR (RTK36)

[0081] SEQ ID NO:23 Bottom strand primer to amplify bacteriophage T3 gene 5′UTR (RTK39)

[0082] SEQ ID NO:24 Top strand primer to amplify maize 16S NEP-PEP (SmaI site) (RTK38)

[0083] SEQ ID NO:25 Bottom strand primer to amplify maize 16S NEP-PEP (BspHI site) (RTK37)

[0084] SEQ ID NO:26 Top strand of EcoRI-XbaI fragment of bacteriophage X2 promoter-like sequence

[0085] SEQ ID NO:27 Bottom strand of EcoRI-XbaI fragment of bacteriophage X2 promoter-like sequence

[0086] SEQ ID NO:28 Top strand primer for kpv1 gene 10 5′UTR

[0087] SEQ ID NO:29 Bottom strand primer for kpv1 gene 10 5′ UTR

Definitions

[0088] For clarity, certain terms used in the specification are defined and presented as follows:

[0089] “Associated with/operatively linked” refer to two nucleic acid sequences that are related physically or functionally. For example, a promoter or regulatory DNA sequence is said to be “associated with” a DNA sequence that codes for an RNA or a protein if the two sequences are operatively linked, or situated such that the regulator DNA sequence will affect the expression level of the coding or structural DNA sequence.

[0090] A “chimeric construct” or “chimeric gene” is a recombinant nucleic acid sequence in which a promoter or regulatory nucleic acid sequence is operatively linked to, or associated with, a nucleic acid sequence that codes for an mRNA or which is expressed as a protein, such that the regulatory nucleic acid sequence is able to regulate transcription or expression of the associated nucleic acid sequence. The regulatory nucleic acid sequence of the chimeric construct is not normally operatively linked to the associated nucleic acid sequence as found in nature.

[0091] A “coding sequence” is a nucleic acid sequence that is transcribed into RNA such as mRNA, rRNA, tRNA, snRNA, sense RNA or antisense RNA. Preferably the RNA is then translated in an organism to produce a protein.

[0092] “Expression cassette” as used herein means a nucleic acid molecule capable of directing expression of a particular nucleotide sequence in an appropriate host cell or compartment of a host cell, comprising a promoter operatively linked to the nucleotide sequence of interest which is operatively linked to termination signals. It also typically comprises sequences required for proper translation of the nucleotide sequence. The coding region usually codes for a protein of interest but may also code for a functional RNA of interest, for example antisense RNA or a nontranslated RNA, in the sense or antisense direction. The expression cassette comprising the nucleotide sequence of interest may be chimeric, meaning that at least one of its components is heterologous with respect to at least one of its other components. The expression cassette may also be one that is naturally occurring but has been obtained in a recombinant form useful for heterologous expression. Typically, however, the expression cassette is heterologous with respect to the host, i.e., the particular DNA sequence of the expression cassette does not occur naturally in the host cell and must have been introduced into the host cell or an ancestor of the host cell by a transformation event. The expression of the nucleotide sequence in the expression cassette may be under the control of a constitutive promoter or of an inducible promoter that initiates transcription only when the host cell is exposed to some particular external stimulus. In the case of a multicellular organism, such as a plant, the promoter can also be specific to a particular tissue or organ or stage of development.

[0093] With respect to plastid transformation the expression cassette is designed in such a way that the promoter, the terminator and other regulatory sequences are functional within the plastids.

[0094] The term “gene” is used broadly to refer to any segment of DNA associated with a biological function. Thus, genes include coding sequences and/or the regulatory sequences required for their expression. Genes also include nonexpressed DNA segments that, for example, form recognition sequences for other proteins. Genes can be obtained from a variety of sources, including cloning from a source of interest or synthesizing from known or predicted sequence information, and may include sequences designed to have desired parameters.

[0095] The terms “heterologous” and “exogenous” when used herein to refer to a nucleic acid sequence (e.g. a DNA sequence) or a gene, refer to a sequence that originates from a source foreign to the particular host cell or, if from the same source, is modified from its original form. Thus, a heterologous gene in a host cell includes a gene that is endogenous to the particular host cell but has been modified through, for example, the use of DNA shuffling. The terms also include non-naturally occurring multiple copies of a naturally occurring DNA sequence. Thus, the terms refer to a DNA segment that is foreign or heterologous to the cell, or homologous to the cell but in a position within the host cell nucleic acid in which the element is not ordinarily found. Exogenous DNA segments are expressed to yield exogenous polypeptides.

[0096] A “homologous” nucleic acid (e.g. DNA) sequence is a nucleic acid (e.g. DNA) sequence naturally associated with a host cell into which it is introduced.

[0097] “homoplasmic” refers to plastids, plant cells and plants comprising only one single, uniform type of plastome copies, i.e. it refers to plastids which do not comprise different plastome copies or to plant cells or plants which do not comprise mixed plastid populations.

[0098] In the context of the present invention, an “isolated” DNA molecule or enzyme is a DNA molecule or enzyme that, by the hand of man, exists apart from its native environment and is therefore not a product of nature. An isolated DNA molecule or enzyme may exist in a purified form or may exist in a non-native environment such as, for example, in a transgenic host cell.

[0099] “Linked with” refers to a first nucleic acid sequence is linked with a second nucleic acid sequence when the sequences are so arranged that the first nucleic acid sequence affects the function of the second nucleic acid sequence. Preferably, the two sequences are part of a single contiguous nucleic acid molecule and more preferably are adjacent. For example, a promoter is operably linked to a nucleic acid encoding a protein if the promoter regulates or mediates transcription of the coding sequence in a cell. The term “nucleic acid” refers to deoxyribonucleotides or ribonucleotides and polymers thereof in either single- or double-stranded form. Unless specifically limited, the term encompasses nucleic acids containing known analogues of natural nucleotides which have similar binding properties as the reference nucleic acid and are metabolised in a manner similar to naturally occurring nucleotides. Unless otherwise indicated, a particular nucleic acid sequence also implicitly encompasses conservatively modified variants thereof (e.g. degenerate codon substitutions) and complementary sequences and as well as the sequence explicitly indicated. Specifically, degenerate codon substitutions may be achieved by generating sequences in which the third position of one or more selected (or all) codons is substituted with mixed-base and/or deoxyinosine residues (Batzer et al., Nucleic Acid Res. 19: 5081 (1991); Ohtsuka et al., J. Biol. Chem. 260: 2605-2608 (1985); Rossolini et al., Mol. Cell. Probes 8: 91-98 (1994)). The terms “nucleic acid” or “nucleic acid sequence” may also be used interchangeably with gene, cDNA, and mRNA encoded by a gene.

[0100] “ORF” means open reading frame.

[0101] “Plastid lethal compound” refers to any compound affecting the viability of a wild-type plant cell plastid. Compounds affecting the viability of a wild-type plant cell plastid include, but are not limited to, compounds that rapidly degrade plastid membranes, inhibit plastid metabolic pathways (such as aromatic amino acid biosynthesis, photosynthesis, chlorophyll biosynthesis, ammonium assimilation, etc.), toxic compounds, proteases, nucleases, compounds that alter the pH of the cell, etc. Preferably, the plastid lethal compound degrades the inner and outer membranes of a wild-type plant cell plastid. Examples of such compounds include any herbicide, which includes but not limited to, glyphosate, butafenacil, phosphoinothricin, norfluorazone, atrizine, glufosinate, bromoxynil, and acifluorfen.

[0102] One skilled in the art will recognize that the ability of plastid lethal compounds to affect plastid viability is dependent upon the concentration of the compound in the medium, the length of time of exposure, and the plant tissue type and/or source.

[0103] “Plastid non-lethal compound” refers to compounds that affect the metabolism of the plant cell plastid and therefore slow or inhibit growth of the plastid or the cell as a whole but do not affect the viability of the plastid or the plant cell during the initial phase.

[0104] “Plastid transformation” refers to the genetic transformation of a plant cell or plant wherein foreign DNA sequences are delivered to the plastids and integrated into the plastid genome (plastome).

[0105] Two nucleic acids are “recombined” when sequences from each of the two nucleic acids are combined in a progeny nucleic acid. Two sequences are “directly recombined” when both of the nucleic acids are substrates for recombination. Two sequences are “indirectly recombined” when the sequences are recombined using an intermediate such as a cross-over oligonucleotide. For indirect recombination, no more than one of the sequences is an actual substrate for recombination, and in some cases, neither sequence is a substrate for recombination.

[0106] “Regulatory elements” refer to sequences involved in controlling the expression of a nucleotide sequence. Regulatory elements comprise a promoter operatively linked to the nucleotide sequence of interest and termination signals. They also typically encompass sequences required for proper translation of the nucleotide sequence.

[0107] “Transformation” is a process for introducing heterologous DNA into a plant cell, plant tissue, or plant. Transformed plant cells, plant tissue, or plants are understood to encompass not only the end product of a transformation process, but also transgenic progeny thereof.

[0108] “Transformed”, “transgenic”, and “recombinant” refer to a host organism such as a bacterium or a plant into which a heterologous nucleic acid molecule has been introduced. The nucleic acid molecule can be stably integrated into the genome of the host or the nucleic acid molecule can also be present as an extrachromosomal molecule. Such an extrachromosomal molecule can be auto-replicating. Transformed cells, tissues, or plants are understood to encompass not only the end product of a transformation process, but also transgenic progeny thereof. A “non-transformed”, “non-transgenic”, or “non-recombinant” host refers to a wild-type organism, e.g., a bacterium or plant, which does not contain the heterologous nucleic acid molecule.

[0109] “transplastomic” refers to plastids, plant cells and plants comprising transformed plastomes.

DETAILED DESCRIPTION OF THE INVENTION

[0110] Section I: Plastid Transformation with Stable Integration of a Lethal Selectable Marker and A) Transient Integration or B) Unstable Integration of a Non-Lethal Selectable Marker A. Plastid Transformation with Stable Integration of a Lethal Selectable Marker and Transient Integration of a Non-Lethal Selectable Marker

[0111] The present invention provides methods for producing transgenic plants having recombinant plastid genomes without the stable integration of an antibiotic resistance marker.

[0112] One aspect of the present invention provides plastid transformation vectors useful for obtaining transformed plastids. The vectors comprise a chimeric lethal selectable marker nucleic acid sequence encoding a protein that provides tolerance to a cell lethal compound and a chimeric non-lethal selectable marker nucleic acid sequence encoding a protein that provides resistance to a plastid non-lethal selective compound. In a vector according to the invention the lethal selectable marker nucleic acid sequence is flanked by plastid targeting sequences whereas the non-lethal selectable marker nucleic acid sequence is located in the backbone of the vector outside of the plastid targeting sequences.

[0113] The chimeric lethal selectable marker nucleic acid sequence preferably comprises a promoter sequence functional in the plastid, a regulatory 5′-untranslated region (5′UTR), a DNA sequence encoding a protein conferring tolerance to a cell lethal compound and a 3′-untranslated region (3 ′UTR).

[0114] The chimeric non-lethal selectable marker nucleic acid sequence preferably comprises a promoter sequence functional in the plastid, a regulatory 5′UTR, a DNA sequence encoding a non-lethal selectable marker encoding a protein conferring resistance to a plastid non-lethal compound, and a 3′UTR.

[0115] Another aspect of the present invention provides plastid transformation vectors useful for obtaining transformed plastids and integrating DNA sequences into the plastid genome. Such DNA sequences can, for example, be genes, chimeric nucleic acid sequences or molecules, or expression cassettes for expression of a gene product or gene products within the transformed plastids. These plastid transformation vectors contain in addition to the previously described features at least one such DNA sequence that is linked to the chimeric lethal selectable marker nucleic acid sequence within plastid targeting sequences. An expressible DNA sequence typically comprises a promoter sequence functional in the plastid, a regulatory 5′UTR, at least one DNA segment encoding a gene product of interest and a 3′UTR. Alternatively, the DNA sequence encoding one or several gene products and the chimeric lethal selectable marker can be expressed from a single promoter in an operon-like polycistronic gene.

[0116] Numerous methods known to those skilled in the art are used in making the constructs and vectors of the present invention such as, but not limited to, ligation, restriction enzyme digests, polymerase chain reaction (PCR), in vitro mutagenesis, linkers and adapters additions, etc, and are described for example, in Sambrook et al., Molecular Cloning: a laboratory manual, 2nd ed. (1989). Therefore, nucleotide transitions, transversions, insertions, deletions may be performed on nucleic acid molecules that are employed in the regulatory regions, the nucleic acid sequences of interest for expression in the plastids.

[0117] The present invention also provides methods for transforming plastids using a two-step selection protocol with plastid non-lethal compounds and cell lethal compounds. Initial plastid transformants are selected on a medium containing a plastid non-lethal compound. The selection is facilitated by the expression of a transiently integrated non-lethal selectable marker gene in the plastid genome. Once a sufficient number of transformed plastids per cell has accumulated, the non-lethal compound medium is replaced by a medium containing a cell lethal compound that selects for plastid genomes expressing the protein that confers tolerance to this compound.

[0118] Alternatively, initial transformants are selected on a medium containing both, a plastid non-lethal compound and a cell lethal compound. Once a sufficient number of transformed plastids per cell accumulated, the selection is continued on medium containing the cell lethal compound only.

[0119] In a preferred embodiment of the invention the plastid non-lethal compound is an antibiotic and the non-lethal marker is an antibiotic resistance gene.

[0120] In another preferred embodiment the cell lethal compound is a herbicide, preferentially a herbicide from the group of PPO inhibitors.

[0121] Plastid Transformation with Stable Integration of ppo and Transient Integration of aadA

[0122] In a preferred embodiment of the present invention the lethal selectable marker gene is a protoporphyrinogen oxidase (ppo) conferring tolerance to the cell lethal compound butafenacil, and the non-lethal selectable marker gene is aminoglycoside adenyltransferase (aadA) conferring resistance to the plastid non-lethal compound spectinomycin.

[0123] The present invention provides a method for producing a transgenic plant having recombinant plastid genomes without stable integration of an antibiotic selectable marker such as aadA. Initial plastid transformants are selected on spectinomycin containing medium based on the expression of the aadA gene which is transiently integrated into the plastid genome. Once a sufficient number of transformed plastids per cell has accumulated, tolerance to butafenacil is conferred to the cell by the expression of the ppo gene which is stably integrated into the plastome. The removal of the antibiotic resistant gene and the segregation and selection of homoplasmic transformants is achieved by switching from spectinomycin to butafenacil selection.

[0124] B. Plastid Transformation with Stable Integration of a Lethal Selectable Marker and Unstable Integration of a Non-Lethal Selectable Marker

[0125] The present invention provides a method to stably integrate a transgene or transgenes of interest into the plastid genome by targeting it into a non-essential plastid genome region wherein the selectable marker is unstably inserted into the plastid genome by targeting it to the plastid genome in such a way that it disrupts an essential plastid gene. This invention is based on the fact that targeted disruption of essential plastid genes is unstable because the disrupted genes revert to their wild-type conformation when the selective pressure is removed Plastid genomes possess several genes (such as ycf1, ycf2 and clpP) that are essential for cell survival. Previous attempts to inactivate such genes by targeted disruption with selectable marker genes (Shikanai et al., Plant Cell Physiol. 42:264-73, 2001; Drescher et al., Plant J. 22:97-104, 2000; Boudreau et al., Mol. Gen. Genet. 253:649-53, 1997; Huang et al., Mol. Gen. Genet. 244:151-9, 1994) could only produce heteroplasmic populations of plastid comprising both, the disrupted and wild-type genes. The insertion of the selectable marker into these genes is unstable and removal of the selective pressure results in the loss of the selective marker and in the reversion to homoplasmic plastid populations having only wild-type copies of the essential gene (Drescher et al., Plant J.22:97-104, 2000; Fischer et al., Mol. Gen. Genet. 251:373-80, 1996).

[0126] One aspect of the present invention provides plastid transformation vectors useful for obtaining transformed plastids. The plastid transformation vector comprises a DNA segment homologous to a plastid locus containing at least a part of an essential plastid gene sequence and an adjacent non-essential plastid sequence, such as an intergenic region. The vectors comprise a chimeric non-lethal selectable marker gene, encoding a protein which provides resistance to a plastid non-lethal compound, wherein the non-lethal selectable marker gene is inserted into the essential plastid gene sequence. The vector further comprises a chimeric lethal selectable marker gene, encoding a protein that provides tolerance to a cell lethal compound, wherein the lethal selectable marker gene is inserted into the non-essential sequence plastid sequence. The chimeric lethal selectable marker gene comprises a promoter sequence functional in the plastid, a regulatory 5′UTR, a DNA sequence encoding a protein conferring tolerance to a cell lethal compound, and a plastidic 3′UTR.

[0127] The chimeric non-lethal selectable marker gene comprises a promoter sequence functional in the plastid, a regulatory 5′UTR, a DNA sequence encoding a protein conferring resistance to a plastid non-lethal compound, and a 3′UTR. Both, lethal and non-lethal selectable marker cassettes are flanked by plastid DNA sequence for targeted insertion in the plastid genome by homologous recombination. The plastid DNA sequence linking the genes to be inserted need to be sufficiently long to allow both, linked and unlinked recombination of the genes with the plastid genome. Preferentially, such linking plastid DNA sequences are at least 200 bp long.

[0128] Another aspect of the present invention provides plastid transformation vectors useful for obtaining transformed plastids and for expressing a gene product or gene products within the transformed plastids. The plastid transformation vectors comprise in addition to the previously described plastid targeting segments with selectable marker genes at least one expressible DNA sequence that is linked to the chimeric lethal selectable marker gene in the non-essential sequence. The expressible DNA sequence comprises a promoter sequence functional in the plastid, a regulatory 5′UTR, a DNA segment encoding a gene product and a plastidic 3′UTR.

[0129] Alternatively, the DNA sequence encoding one or several gene products and the chimeric lethal selectable marker are expressed from a single promoter in an operon-like polycistronic gene.

[0130] The present invention also provides methods for transforming plastids using a two-step selection protocol with plastid non-lethal and cell lethal compounds. Initial plastid transformants are selected on a medium containing a plastid non-lethal compound. The selection is facilitated by the expression of a non-lethal selectable marker gene integrated in the targeted plastid essential gene. Once a sufficient number of transformed plastids per cell has accumulated, the non-lethal compound medium is replaced by a medium containing a cell lethal compound that selects for plastid genomes expressing the protein that confers tolerance to this compound. After several rounds of tissue subculture on lethal selective media the plastid genomes are rendered homoplasmic for the lethal selectable marker gene or the lethal selectable marker with expressible DNA sequence(s), and wild-type for the targeted essential gene.

[0131] Alternatively, initial transformants are selected on a medium containing both, a plastid non-lethal compound and a cell lethal compound. Once a sufficient number of transformed plastids per cell has accumulated, the selection is continued on medium containing a cell lethal compound only.

[0132] Plastid Transformation with Stable Integration of ppo and Unstable Integration of aadA

[0133] In a preferred embodiment of the present invention the lethal selectable marker gene is protoporphyrinogen oxidase (ppo) conferring tolerance to the cell lethal compound butafenacil, and the non-lethal selectable marker gene is aminoglycoside adenyltransferase (aadA) conferring resistance to the plastid non-lethal compound spectinomycin. The present invention provides a method for producing a transgenic plant having recombinant plastid genomes without stable integration of an antibiotic selectable marker such as aadA. Initial plastid transformants are selected on spectinomycin containing medium based on the expression of the aadA gene which is unstably integrated into the plastid genome, disrupting an essential plastid gene. Once a sufficient number of transformed plastids per cell has accumulated, tolerance to butafenacil is conferred to the cell by the expression of the ppo gene which is stably integrated into the plastome. The reversion of the disrupted essential plastid gene to the wild-type gene and the segregation and selection of homoplasmic transformants is achieved by switching from spectinomycin to butafenacil selection.

[0134] Section II: Methods for Selecting Homoplasmic Transplastomic Plants Expressing the ppo Gene in their Plastids

[0135] The invention relates to methods for selecting homoplasmic plant cells or plants comprising transplastomic plastids having the ppo gene integrated into their plastome with the exclusion of any antibiotic resistance gene.

[0136] These methods employ a ppo plastid expression cassette, which is flanked by a sequence homologous to plastid DNA, an aadA plastid expression cassette, which is apart from the flanking sequence of the ppo cassette, and either one of the two phase selection strategies provided by the invention, comprising using the ppo gene as selectable marker gene during the segregation phase of heteroplasmic plastid populations and the selection of homoplasmic plant cells to obtain transplastomic plants having the ppo gene integrated into their plastome with the exclusion of the antibiotic resistance gene aadA.

[0137] A further aspect of the invention relates to the extension of plastid transformation methods to non pigmented plant material. The invention provides selection strategies comprising using a lethal selectable marker gene for plastid transformation and a cell lethal compound such as Formula XVII as selective agent, wherein green pigmentation is not essential for the selected transplastomic phenotype. These selection strategies therefore have the potential to be applied to green tissue as well as to non-green tissue for plastid transformation.

[0138] The lethal selectable marker gene ppo and the antibiotic resistance gene aadA are co-delivered into the transformation targets in the same or in separate constructs, wherein the ppo cassette comprises its own flanking sequence which is homologous to a plastid DNA fragment, while the aadA cassette is apart from the flanking sequence of the ppo cassette. The ppo cassette comprises a 5′-promoter, the ppo gene, and a 3′UTR, designed for expression in the plastid, while the aadA cassette comprises a 5′-promoter, the aadA gene and a 3′UTR, designed for expression in the plastid.

[0139] The selection procedure consists of two phases. During the first selection phase, cells containing transplastomic plastids are selected on medium comprising the non-lethal selective compound spectinomycin or streptomycin. Alternatively, the selection medium used during the first selection phase comprises spectinomycin or streptomycin in combination with the herbicide Formula XVII as a cell-lethal selective agent.

[0140] The selection of the first phase on medium containing the non-lethal compound is carried out for a period of time in which resistant events are not yet visually detectable. A person skilled in the art will know how to determine this time period, e.g. based on tissue culture parameters which are specific for the plant species to be transformed. The first selection phase lasts for about five days to about eight weeks, more specifically for about one week to about six weeks. Preferentially, the first selection phase is about two to four weeks.

[0141] Alternatively, the first selection phase can be extended until resistant events become visually detectable. Depending on the plant species to be transformed and the type of explant used resistant events become visible after about one week to about fifteen weeks, more specifically after about three weeks to about ten weeks. When the first selection phase is extended until resistant events are visually detectable, the first selection phase typically lasts for about five weeks.

[0142] The second selection phase which follows the initial selection on spectinomycin is carried out on medium containing the cell-lethal agent Formula XVII as selective agent. The segregation and selection process during this phase results in the rapid loss of the antibiotic resistant gene aadA and the establishment of a homoplasmic plastid population having the ppo gene stably integrated into the plastome. The thus obtained transplastomic cells are then regenerated into homoplasmic plants which express the ppo gene in their plastids and which transmit the transplastomic plastids to their progenyThe homoplasmic PPO transplastome plants result in much higher herbicide tolerance than nuclear transformed plants with the same gene. Furthermore, much higher herbicide resistance is obtained with homoplasmic transplastomic expressing the ppo gene in their plastids plants than with nuclear transformants expressing ppo in the nucleus.

[0143] Any method know for transforming plant cell plastids available may be employed in the present invention that result in plant cells containing a population of plastids into which have been introduced a recombinant nucleic acid construct having a DNA sequence encoding for a protein that provides tolerance to a plastid lethal compound or a plastid non-lethal compound as the case may be. Plastid transformation methods include, but are not limited to, particle bombardment, PEG mediated transformation,

[0144] Stable transformation of tobacco plastid genomes by particle bombardment has been reported (Svab et al. (1990) Proc. Natl. Acad. Sci. USA 87:8526-8530; Svab and Maliga (1993) Proc. Natl. Acad. Sci. USA 90:913-917) and PEG mediated transformation of plastids is described by Koffer et al. (1998) in Vitro Cell. Biol.-Plant, 34:303-309 Other methods for introducing recombinant constructs into plant cell plastids are known in the art, and are described for example in Svab et al. (1990) Proc Natl. Acad. Sci. USA 87:8526-8530, Sikdar et al. (1998) Plant Cell Reports 18:20-24, PCT Publication WO 97/2977, and Sidorov et al. (1999) Plant J. 19(2):209-216. Additional methods for introducing two constructs into a plant cell plastid are described for example in Carrer et al. Biotechnology 13:791-794 (1995). The methods described in the above references may be employed to obtain plant cells transformed with the plastid transformation constructs described herein.

[0145] The regeneration of whole plants from a transformed cell contained in the tissue used in transformation involves several growth stages. Typically, a tissue, having been excised from an adult plant or germinated seedling, is placed on a chemically defined medium under sterile conditions. By growing the explant under such controlled conditions for a period of time, an undifferentiated mass of cells, referred to as a callus, may form. By culturing this callus under the proper set of conditions, e.g., nutrients, light, temperature, humidity, and by providing the proper combination and concentration of plant growth regulators, the calli may be induced to form differentiated cells and regenerate plant shoots. Plant shoots, sometimes referred to as plantlets, containing meristem tissue are then transferred to a media for the induction of root production.

[0146] The selective media used and described herein may be liquid or solid, such as by the addition of a solidifying agent, such as agar. Liquid selective media allows for greater surface area of contact of the plant tissue with the selective media containing particular hormones, particular selective agents and other substances necessary to obtain regeneration.

[0147] The above disclosed embodiments are illustrative. This disclosure of the invention will place one skilled in the art in possession of many variations of the invention. All such obvious and foreseeable variations are intended to be encompassed by the appended claims.

EXAMPLES

Example 1

Preparation of the Plastid Transformation Vector for Transient Integration of aadA

[0148] I. Amplification of the Maize Plastid 16S PEP-NEP rRNA Gene Promoter Fused to the N. tabacum Plastid rbcL Ribosome Binding Site (RBS)

[0149] The Maize 16S PEP-NEP rRNA gene promoter (Zea mays complete chloroplast genome, accession number X86563, position 94966 to 95115) was isolated by PCR amplification from Maize 6N615 DNA using a top strand primer comprising an introduced EcoRI restriction site at the 5′end of the 16S rRNA gene promoter region (SEQ ID NO: 5; 5′-GCCAGAATTCACCACGATCGAACGGGAATGGATA-3′, EcoRI site is underlined) and a bottom strand primer that extends to the 16 S rRNA gene promoter, mutates one ATG downstream of the transcription start site by changing position (T to G), fuses the tobacco rbcL RBS (N. tabacum complete chloroplast genome, accession number NC—001879 position 577569 to 57585) as a 5′-extension to the 3′-end of the 16S rRNA gene 5′UTR and introduces a BspHI site at the 5′-end of the RBS (SEQ ID NO: 6; 5′-GCCGTCATGAATCCCTCCCTACAACTGATTCGGAATTGTCTTTCCTTCCAAGGATA ACTFGTATCCAGGCGCTTCAG-3′, BspHI restriction site is underlined). PCR amplification was performed with the Pfu Turbo DNA polymerase kit (Stratagene, LaJolla Calif.) in a Perkin Elmer Thermal Cycler 480 according to the manufacturer's recommendations (Perkin Elmer/Roche, Branchburg. N.J.) as follows: 5 min 95° C., followed by 5 cycles of 1 min 95° C./2 min 49° C./1 min 72° C., then 25 cycles of 1 min 95° C./2 min 55° C./1 min 72° C.

[0150] The DNA sequence of the maize plastid 16S PEP-NEP rRNA gene promoter fused to the N. tabacum plastid rbcL ribosome binding site (RBS) is provided in SEQ ID NO:4. In the representation of SEQ ID NO:4 below the 16S rRNA gene promoter sequence is underlined; the mutated nucleotide is in bold; the initiation codon (ATG) is in small caps:

1 GAATTCACCACGATCGAACGGGAATGGATAAGAGGCTTGTGGGATTGACG
50 TGATAGGGTAGGGTTGGCTATACTGCTGGTGGCGAACTCCAGGCTAATAA
100 TCTGAAGCGCCTGGATACAAGTTATCCTTGGAAGGAAAGACAATTCCGAA
150 TCAGTTGTAG GGAGGGATTC atg

[0151] II. Construction of a Maize 16S rRNA Promoter Fused to the N. tabacum rbcL Gene Ribosome Binding Site (RBS), the Arabidopsis thaliana ppo Gene and N. tabacum Plastid rps16 3′UTR Cassette for Plastid Selection.

[0152] The chimeric A. thaliana ppo gene was created through the following cloning steps. The plasmid pAT259 containing the Arabidopsis ppo coding sequence was created by ligating a 450 bp EcoRI-SfuI comprising part of the Arabidopsis ppo gene which contains the pAraC-2Met and pAra305 Leu point mutations (described in U.S. Pat. No. 6,084,155) to a 4.1 kb EcoRI-SfuI fragment from pPH141 (also described in U.S. Pat. No. 6,084,155). A SpeI restriction site was added at the 3′ end of ppo gene by PCR amplification using pAT259 as DNA template and the following top strand primer (SEQ ID NO: 7; 5′-CCACGCACGCAAGGAGTTGA-3′) and the bottom strand primer (SEQ ID NO: 8; 5′-CGGTACTAGTCTGGGAGATTTAATGTT-3′, SpeI restriction site is underlined).

[0153] The plasmid pAT260 was formed by ligating the 2.8 bp NcoI-SpeI digested pLITMUS28 vector with a 1.1 kb NcoI-EcoRI fragment from pAT259 containing the 5′-end of the ppo coding sequence and a 337 bp EcoRI-SpeI PCR amplified fragment containing the 3′-end of the ppo gene.

[0154] Plasmid pAT263 was obtained by ligating a 1.5 kb NcoI-SpeI fragment from pAT260 comprising the Arabidopsis ppo coding sequence with a 2.8 kb EcoRI-SpeI fragment from pAT229 (described in WO 00/20612) comprising the tobacco plastid rps16 3′UTR integrated into the pUC19 vector (New England Biolabs) and the 145 bp EcoRI-NcoI Maize 16SrRNA PEP-NEP-rbcL (RBS) PCR amplified promoter sequence.

[0155] III. Amplification and Cloning of the N. tabacum Plastid psbA Promoter.

[0156] The tobacco psbA gene promoter (N. tabacum complete chloroplast genome, accession number NC—00 1879, position 1596 to 1745) was isolated by PCR amplification of DNA isolated from the N. tabacum cv. ‘Xanthi’ using a top strand primer comprising an introduced EcoRI restriction site at the 5′-end of the psbA gene promoter region (SEQ ID NO: 9; 5′-TTAAGAATTCGAATAGATCTACATA-3′, EcoRI site is underlined) and a bottom strand primer comprising an introduced NcoI site at the end of psbA 5′UTR(SEQ ID NO: 10; 5′-CAGCCATGGTAAAATCTTGGTT-3′, NcoI restriction site is underlined). PCR amplification was performed with the Pfu Turbo DNA polymerase kit (Stratagene, LaJolla Calif.) in a Perkin Elmer Thermal Cycler 480 according to the manufacturer's recommendations (Perkin Elmer/Roche, Branchburg, N.J.) as follows: 1 min 94° C., followed by 35 cycles of 1 min 94° C./1 min 45° C./1 min 72° C., then 10 min 72° C. The predicted 16 bp amplification product was digested with EcoRI and NcoI and ligated in the respective sites of pLITMUS28 (New England Biolabs, Beverly Mass.) to form the pPB30 plasmid.

[0157] IV. Preparation of the Chimeric Gene containing N. tabacum psbA Promoter Fused to aadA.

[0158] Plasmid pPB37 comprising the tobacco psbA promoter upstream of the aadA coding sequence, a bacterial gene encoding the enzyme aminoglycoside adenyltransferase that confers resistance to spectinomycin and streptomycin, was obtained by ligating the 2.8 kb EcoRI-SpeI digested pLitmus28 vector with the 149 bp EcoRI-NcoI tobacco psbA promoter fragment from pPB30 and a 813 bp BspHI-SpeI fragment from pAT229 which contains the aadA coding sequence.

[0159] V. Construction of a Chimeric Gene Containing the Arabidobsis thialiana clpP Promoter Fused to a Gus Reporter Gene and the A. thaliana Plastid psbA 3′UTR.

[0160] Plasmid pAT242 comprising a gus chimeric gene was obtained by the following cloning strategy. The A. thaliana clpP promoter was PCR amplified from plasmid pPH146b (described in U.S. Pat. No. 6,362,398 ) using a top strand primer comprising an introduced EcoRI restriction site at the 5′-end of the clpP gene promoter region (SEQ ID NO: 11; 5′-GCGGAATTCATCATTCAGAAGCCCGTTCGT-3′, EcoRI site is underlined) and a bottom strand primer comprising an introduced BspHI site at the 5′-end of clpP 5′UTR (SEQ ID NO:12; 5′-GCGTCATGAAATGAAAGAAAAAGAGAAT-3′, BspHI restriction site is underlined). PCR amplification of the 250 bp fragment was performed with the Pfu Turbo DNA polymerase kit (Stratagene, LaJolla Calif.) in a Perkin Elmer Thermal Cycler 480 according to the manufacturer's recommendations (Perkin Elmer/Roche, Branchburg. N.J.) as follows: 1 min 94° C., followed by 35 cycles of 1 min 94° C./1 min 45° C./1 min 72° C., then 10 min 72° C. pAT242 was created by ligating the 238 bp EcoRI-BspHI fragment from the A. thaliana clpP promoter PCR amplification to a 2.1 kb NcoI-HindIII fragment from pAT221 containing the gus gene linked to the A. thaliana plastid psbA 3′UTR (described in WO 00/20612) and to the 3.2 kb HindIII-EcoRI digested pUC21 vector.

[0161] VI. Insertion of the ppo and aadA Chimeric Genes in a Tobacco Plastid Transformation Vector.

[0162] Plasmid pPB2 having the chimeric ppo and gus genes cloned in opposite orientation was created by ligating a 1.8 kb HindIII-EcoRI fragment from pAT263, which was fully cut with HindIII but only partially cut with EcoRI, containing the Maize 16S rRNA PEP-NEP-rbcL(RBS)::ppo::N. tabacum rps16 3′UTR chimeric gene, a 2.3 kb EcoRI-PstI fragment containing the chimeric A. thaliana clpP promoter::gus::A.thaliana psbA 3′UTR gene from plasmid pAT242 and the 2.9 kb HindIII-PstI digested bluescript SK+vector (Stratagene, LaJolla Calif.). The pPB6 plastid transformation vector was made by flanking the chimeric ppo and gus genes with tobacco chloroplast sequence. A 4.1 kb PstI fragment comprising both chimeric genes from pPB2 was ligated to the PstI linearized pAT218 plasmid (PCT WO 00/20612) containing the plastid targeting sequence. The plastid transformation vector pPB97 was made by replacing the pPB6 gus coding sequence with the A. thaliana clpP promoter by the N. tabacum psbA promoter::aadA gene cassette from plasmid pPB37. A 962 bp EcoRI-SpeI fragment from a fully EcoRI but partially SpeI digested pPB37 plasmid was ligated to a 6.7 kb EcoRI-XbaI fragment from a fully XbaI but partially EcoRI digested pPB6 plasmid.

[0163] II. Creation of the Plastid pEBPPOt Transformation Vector.

[0164] The plastid transformation vector pEBPPOt (SEQ ID NO: 1) for stable integration of the A. thaliana ppo gene into the plastid genome but only transient insertion of the aadA gene was created using the following strategy. The N. tabacum psbA promoter::aadi::A. thaliana psbA 3′UTR chimeric gene was removed from pPB97 by partially digesting the plasmid with EcoRI and fully cutting it with HindIII. Following the restriction digestions the ends of the resulting fragments were rendered blunt with the T4 DNA polymerase. A 6.5 kb fragment comprising the vector with the chimeric ppo gene, the plastid targeting sequence and a 1.2 kb fragment containing the aadA chimeric gene was isolated. The 6.5 kb vector fragment was self ligated to yield pEBPPO. This plasmid was subsequently linearized with NgomIV, rendered blunt with T4 DNA polymerase and ligated to the 1.2 blunt aadA fragment to yield pEBPPOt. Plasmids having the chimeric aadA gene in either orientation was obtained but only the one having aadA oriented towards the bla gene of the vector was retained (FIG. 1).

Example 2

Preparation of a Plastid Transformation Vector for Stable Integration of Exogeneous DNA Linked to the Chimeric ppo Gene Under the Control of the Plastid Maize16S Pep-Nep rRNA Gene Promoter and Transient Integration of a Chimeric aadA Gene Under the Control of the N. tabacum clpP Promoter.

[0165] The plasmid pPB96 was obtained by a four way ligation of the 149 bp EcoRI-NcoI N. tabacum plastid psbA promoter from pPB30, a 1.5 kb NcoI-SpeI fragment from pAT260 containing the A. thaliana ppo coding sequence, a 4.0 kb BamHI-SpeI fragment from pPB67b containing the N. tabacum plastid rps16 3′UTR linked to the N. tabacum 16S rDNA portion of the plastid targeting sequence and the pBluescript SK+vector, and a 1.9 kb EcoRI-BamHI fragment from pPB67b which contains a portion of the rps7/12 plastid targeting sequence. The plastid transformation vector pEB8 was obtained by ligating a NgomIV linearized blunt ended pPB96 plasmid with a 1.2 blunt fragment containing a N. tabacum clpP plastid promoter (described in U.S. Pat. No. 6,084,155) fused to the aadA gene and the N. tabacum plastid rps16 3′UTR chimeric gene yielding plasmid pEB8a and pEB8b, which differ only in the orientation of the chimeric aadA gene in the plasmid. Only pEB8a (SEQ ID NO:2, FIG. 2) having aadA directed towards the bla gene of the vector was retained for plastid transformation.

Example 3

Biolistic Transformation of the Tobacco Plastid Genome with the Plastid Transformation Vectors pEBPPOt and pEB8 and Selection (see Example 6 for a Detailed Description of the Transformation and Selection Methods).

[0166] After delivery of pEBPPOt (FIG. 1, SEQ ID NO: 1) or pEB8 (FIG. 2, SEQ ID NO:2) into the plastid the entire vector integrates into the plastid genome in a first recombination event. Initial plastid transformants are selected by spectinomycin due to the expression of the aadA gene transiently integrated into the plastid genome. Since the cpDNA sequences flanking the ppo gene in the vector provide two different cross-over loci, the recombination between the plastid genome and the vector results in a mixed population of transformed genomes having the inserted vector in different conformation (A and B). Switching to butafenacil selection favors the stable insertion of the ppo gene and the excision of the aadA gene together with the vector backbone sequence. The loss of the vector sequence is mediated by an intra-recombination event between direct repeated DNA sequences that were created when the vector inserted into the genome. Further the segregation of the plastid population under butafenacil selection results in the enrichment of ppo transformed plastid genomes without the aadA marker and will finally lead to homoplasmic cells.

[0167] PCR analysis of DNA samples from selected pEBPPOt and pEB8 events obtained from initial spectinomycin selection showed that both, the aadA and the ppo gene, are present in the transformants. Subsequently, after two to three rounds of subculture on butafenacil containing medium, PCR analysis of DNA samples from same events confirmed the loss of the aadA gene while the ppo gene is retained in the transformants.

[0168] Southern blot analysis was used to demonstrate that the ppo gene could be inserted in the plastid genome to homoplasmicity upon butafenacil selection. Total cellular DNA from ten pEBPPOt transformants that were subjected to three or four subculture rounds on butafenacil selective conditions was analyzed by Southern blot hybridization . DNA of the wild-type and of transformants was digested with BamHI and hybridized with a chloroplast DNA (cpDNA) specific probe. This probe hybridized with a 3.3 kb fragment of wild-type DNA, whereas it predominately hybridized with a 5.1 kb DNA fragment in eight of the transformants indicating that the 1.8 kb ppo gene is inserted to homoplasmicity in most of these events. In lines 4 and 9 both fragments are detectable, indicating the occurrence of a heteroplasmic (mixed) population of wild-type and ppo transformed plastid genomes. Four different plastid genome populations are observed in these lines: a wild-type genome (3.3 kb), a ppo transformed genome (5.1 kb) and vector inserted genomes in two different conformations (vector insertion A and B, 7.6 and 5.8 kb, respectively). Reprobing the BamHI Southern blot with an aadA specific probe, confirmed that the homoplasmic transformants add lost the antibiotic marker and that the vector was inserted in different conformation (7.6 and 5.8 kb BamHI fragments) in the plastid genomes of the heteroplasmic lines 4 and 9. A Southern blot of SpeI digested DNA samples probed with the same aadA probe also showed that only the heteroplasmic lines 4 and 9 have the antibiotic marker (0.9 kb) whereas the other transformants have lost it.

[0169] Southern hybridization analysis of BamHI digested DNA for the identification of homoplasmic pEBPPOt plastid transformants.

[0170] Southern blot analysis was used to demonstrate that exogenous DNA linked to the ppo gene from pEB8 vector could be inserted in the plastid genome to homoplasmicity upon butafenacil selection. Total cellular DNA from two pEB8 transformants that were subjected to four subculture rounds on butafenacil selective conditions was analyzed by Southern blot hybridization. DNA of the wild-type and of transformants was digested with BamHI and hybridized with a chloroplast DNA (cpDNA) specific probe. This probe hybridized with a 3.3 kb fragment of wild-type DNA, whereas it predominately hybridized with a 6.1 kb DNA fragment the transformants indicating that the 2.8 kb sequence containing the exogenous DNA linked to the ppo gene is inserted to homoplasmicity in these events.

Example 4

Preparation of the Plastid Transformation Vector for Unstable Integration of aadA

[0171] I. Cloning of a New Plastid Target Locus

[0172] A 4.7 kb fragment of tobacco plastid DNA (N. tabacum complete chloroplast genome, accession number NC—001879, position 93132 to 97844 and 144782 to 149494) was isolated by PCR amplification of DNA isolated from the N. tabacum cv. ‘Xanthi’ using a top strand primer comprising an introduced XhoI restriction site (SEQ ID NO: 13; 5′-AGTTATCTCGAGTGAGAGAAAGAAGTGAGGAAT-3′, XhoI site is underlined) and a bottom strand primer comprising an XbaI site (SEQ ID NO: 14; 5′-TTCTCTAGAAGAAATACGGGG-3′, XbaI restriction site is underlined). PCR amplification was performed with the Pfu Turbo DNA polymerase kit (Stratagene, LaJolla Calif.) in a Perkin Elmer Thermal Cycler 480 according to the manufacturer's recommendations (Perkin Elmer/Roche, Branchburg. N.J.) as follows: 1 cycle at 95° C. for 5 min where enzyme was added 2 min before the end of the cycle, followed by 30 cycles of 1 min 94° C./1 min 45° C./4 min 72° C., then 1 cycle for 10 min at 72° C. The predicted 4.7 kb amplification product was digested with XhoI and XbaI and ligated in the respective sites of pLITMUS28 (New England Biolabs, Beverly Mass.) to form the pEBNY2 plasmid.

[0173] II. Construction of Novel Plastid Transformation Vector

[0174] The plasmid pEBNY2 was linearized with PstI restriction endonuclease. The chimeric aadA gene was removed from pPB97 by partially digesting the plasmid with EcoRI and fully cutting it with HindIII. Following the restriction digestions the ends the 7.5 kb PstI linearized pEBNY2 plasmid and of the 1.2 kb HindIII-EcoRI fragment containing the aadA chimeric gene were rendered blunt with the T4 DNA polymerase. Subsequently, these fragments were ligated together to yield the plasmid pEBNY2+aadA. Plasmids having the chimeric aadA gene in either orientation were obtained but only the one having aadA oriented in opposite direction of the ycf2 gene was retained.

[0175] The plasmid pEBNY2+aadA was linearized with NdeI restriction endonuclease. The chimeric ppo gene was removed from pEBPPO cutting it with PstI restriction endonuclease. Following the restriction digestions the ends the 8.6 kb NdeI linearized pEBNY2+aadA plasmid and the 1.8 kb PstI fragment containing the chimericppo gene were rendered blunt with the T4 DNA polymerase. Subsequently, these fragments were ligated together to yield the plasmid pNY2C (SEQ ID NO:3, FIG. 3). Plasmids having the chimeric ppo gene in either orientation were obtained but only the one having ppo oriented in the same direction as the ycf2 gene was retained.

Example 5

Biolistic Transformation of the Tobacco Plastid Genome with pNY2C and Selection (see Example 6 for a Detailed Description of the Transformation and Selection Method)

[0176] After delivery of the vector DNA into the plastid, transformants are selected for spectinomycin resistance, which is conferred by the aadA gene integrated into the essential ycf2 gene. The plastid sequences flanking both selectable marker genes within the plastid transformation vector provides 3 different recombination loci and different combinations of double crossover events will produce a mix population of transformed plastid genomes having either one or both selectable markers. Switching to butafenacil selection will result in the segregation of the mixed plastid genome population and the selection of homoplasmic plastids expressing the ppo gene. The natural selective pressure will favor the wild-type copy of the essential gene and will thus result in the complete loss of the aadA gene.

[0177] PCR analysis of DNA samples from events obtained from initial spectinomycin selection showed that both, the aadA and the ppo genes are present in the transformants. Subsequently, after two to three rounds of subculture on butafenacil, PCR analysis of DNA samples from the same events confirmed the loss of the aadA gene while the ppo gene is retained in the transformants.

[0178] Southern blot analysis was used to demonstrate that the ppo gene could be inserted into the plastid genome and that homoplasmic cells were obtained upon butafenacil selection. Total cellular DNA from 20 transformants that were subjected to three or four subculture rounds on butafenacil containing medium was analyzed by Southern blot hybridization. The DNA from wild-type and transformants was digested with NcoI and hybridized with a DNA probe specific to tobacco plastid sequence (NC—001879, positions 96811 to 97844). This probe, which normally recognizes a 2.6 kb NcoI fragment in the wild-type, predominately hybridized with a 4.4 kb DNA fragment in all of the transformants, indicating that the 1.8 kb ppo gene is stably inserted into the plastome and that homoplasmic transformants have been selected in these events.

[0179] Southern blot analysis also revealed that aadA insertion into the essential ycf2 gene upon spectinomycin selection is unstable. Southern analysis from DNA samples taken from those 20 transformants after initial selection on spectinomycin containing medium which were described above indicated that the aadA chimeric gene was inserted into the targeted essential plastid gene but that the cells remained in the heteroplasmic state as a certain portion of wild-type copies was retained. A tobacco plastid DNA probe (NC—001879 position 94408 to 95861) specific for the aadA plastid-targeting locus hybridized to both the wild-type 1.4 kb fragment and a 2.6 kb fragment containing the aadA insertion in every transformants. After several rounds on butafenacil selection the probe only recognized the 1.4 kb wild-type DNA fragment indicating that all the genomes reverted to the wild-type and that the aadA gene was lost when the spectinomycin selection pressure was removed. Furthermore, no hybridization signal was observed when the Southern blot was hybridized with an aadA specific probe.

Example 6

Plastid Transformation and Selection

[0180] I. Seed Germination

[0181] Tobacco (Nicotiana tabacum) seeds are sterilized with 70% ethanol for several minutes, rinsed three to five times with sterile water, and then plated onto germination media (Table 2, 3). Germination plates are incubated at around 25° C. with 12-16 hours photoperiod. The Germination medium (GM) is as follows: MS Macro-salts ½×; MS Micro-salts 1×x; GM vitamins (100×) 10 mV/L; Na2EDTA 75 mg/L; FeCl3 6H2O 27 mg/L; Sucrose 10 g/L; Phytagar 8 g/L; and pH adjusted to 5.5.

[0182] The GM vitamins (100×) are mixes as follows: Inositol 10 g/L; Biotin 5 mg/L; Pyridoxine 50 mg/L; Thiamine 50 mg/L; Nicotinic Acid 500 mg/L; Folic Acid 50 mg/L; and Glycine 200 mg/L.

[0183] II. Explant Preparation and DNA-Delivery

[0184] Leaves of approximately 2 week old tobacco seedlings are placed with the adaxial side (“upper side”) up in the center of plates containing tobacco culture medium (Table 4) Alternatively the vitamins in this medium can be replaced by 100 mg/L inositol and 1 mf/L thiamine. The particle bombardment is performed on the same day. The Tobacco culture medium is as follows: MS Salts 1×; MS Vitamins ½×; B5 Vitamins ½×; BAP 1 mg/L; NAA 0.1 mg/L; Sucrose 30 g/L; and Sigma purified agar 6 g/L with the pH adjusted to 5.8.

[0185] DNA-particle preparation is performed as follows: 60 mg of particles (tungsten or gold) are sterilized with 0.5 ml of 70% ethanol, washed twice with 0.5 ml sterile double distilled water, and then resuspended in 1 ml of 50% glycerol. To a 100 μl aliquot of the particle suspension, 10 μg of DNA, 100 μl of 2.5M CaCl2, 50 μl of 0.1 M spermidine is added sequentially and mixed gently with each adding. The DNA coated particles are centrifuged briefly, followed by one wash with 200 μl of 70% ethanol and another wash with 200 μl of 100% ethanol. Then they are resuspended in 100 μl of 100% ethanol. For each bombardment, 5 to 10 μl of DNA-particles are used.

[0186] The bombardment is carried out using the PDS 1000 Helium gun (Bio-Rad, Richmond, Calif.), following a modification of the protocol described by the manufacturer. Plates with the target explants are placed on the third shelf from the bottom of the vacuum chamber, bombarded with 650 p.s.i. rupture disks with single or multiple shots per plate.

[0187] III. Selection of Homoplasmic Transplastomic Plants Expressing the ppo Gene in their Plastids

[0188] a) Initial Selection

[0189] The initial selection is carried out with spectinomycin as the selection agent, or with the combination of spectinomycin and Formula XVII in the case of dual selection. Spectinomycin is added at 500 mg/L to tobacco culture media in either case, while Formula XVII is added in the media at concentrations of about 2 nM to about 10 nM, preferably about 5 nM to about 25 nM or alternatively, about 25 to about 50 nM.

[0190] One week after the bombardment, the explants are transferred to tobacco culture media containing the selection agent(s), with the bombarded sides directly contacting the selection medium. When Formula XVII is included in the selection media, it is preferred to cut the explants into small pieces, to facilitate more efficient selection. After about two to four weeks of selection on spectinomycin containing medium, the explants or, if identifiably, the resistant transformants are carried further to the next phase of the selection to obtain homoplasmic plants expressing the ppo gene in their plastids.

[0191] The selection phenotype of the dual selection system is notably different from the phenotype obtained with sole spectinomycin selection. With the sole spectinomycin selection, the selection phenotype is pigmented green, in which the green pigmented transformants are identified against the white non-transformed tissue. In contrast, on the selection media containing Formula XVII, the transformants always appear as white to yellowish calli, on a background of brown non-transformed tissue.

[0192] The selection phenotype with lethal selection compound Formula XVII is particularly important for the selection of those tissue types which would not turn to green under the culture conditions used for the selection. It is more desirable and practicable to select white or yellowish tissue against the brown tissue, as in the case with lethal compound Formula XVII, than select white or yellowish tissue against the white tissue.

[0193] b)Secondary Selection of Homoplasmic Events Expressing ppo Gene in the Plastome.

[0194] The bombarded explants or the selected primary transformants are transferred to tobacco culture media containing only Formula XVII as the selection agent at concentrations of either about 25 nM to about 50 nM or about 50 nM to about 250 nM for further segregation and selection. The tissues are cut into small pieces during the culture and every subculture thereafter, to ensure better contact of the tissue to the media, and thus more efficient selection. After several rounds of selection, samples of the transformants are collected and analyzed by Southern Blot. Out of ten independent transformants analyzed, eight were confirmed to be homoplasmic transformants having the ppo gene integrated into their plastome but not the aadA gene. The other two events were heteroplasmic containing both genes (Table 1).

[0195] IV. Regeneration of Homoplasmic Plants and Expression of the ppo Gene in the Plastids

[0196] Homoplasmic ppo events are regenerated to form shoots on tobacco culture media containing the selection agent. The concentration of cytokinin in the medium may be doubled to enhance regeneration. The shoots obtained are rooted individually on hormone-free tobacco culture media, with or without the selection agent.

[0197] The homoplasmy of each individual plant transferred to the greenhouse was confirmed by southern blotting or PCR. All plants are fertile and exhibit a normal phenotype.

[0198] The expression of the ppo gene in homoplasmic plants is evaluated by an ELISA assay. The data obtained were compared to that of tobacco nuclear transformants expressing the ppo gene in the nucleus. The ELISA assay demonstrated a significant increase of the PPO protein concentration in the transplastomic plastid plants compared to nuclear transformants (Table 5).

TABLE 1
Quantification of the PPO protein in homoplasmic transplastomic
plants and in nuclear transformants expressing the ppo gene.
		PPO protein		PPO protein
		per total		per total
	Plastid Event	protein	Nuclear event	protein
	Number	[ng/mg]	number	[ng/mg]
	814	127.12	2200	6.0
	815	138.43	2203	2.4
	816	147.72	2212	0.1
	818	143.90	2213	2.6

Example 7

Tomato Plastid Transformation

[0199] Syngenta elite tomato genotype ZTV840 was used for plastid transformation. Seed sterilization, germination and the leaf bombardment were performed as previously described for tobacco plastid transformation (Example 6).

[0200] Two days after the bombardment, the tomato leaves were transferred to the selection medium with 500 mg/L spectinomycin, and cultured in dim light. One month later, the leaves were cut into small pieces and subcultured to the same selection medium. Transplastomic events bega to appear after two months of the selection. Two events were obtained from 10 plates bombarded with a stable aadA-PPO construct, and another two events from 11 plates bombarded with the transient aadA: stable PPO construct (pEBPPOt).

[0201] When the four events just showed up, they consisted of very friable, soft calli with a little bite of green color. These events were then transferred to medium containing 50 to 75 nM of Formula XVII for the second selection phase. Three of the four events survived Formula XVII selection and continued to grow on the selection media for more than six months.

Example 8

High Level of Herbicide Tolerance Obtained with Homoplasmic PPO Transplastomic Plants

[0202] Much higher levels of herbicide tolerance is obtained with transplastomic homoplasmic plants expressing ppo in their plastids than with ppo expressing nuclear transformants. PPO transplastomic tobacco plants were survived very well with Formula XVII treatmentup to the concentration of 2000 nM, the highest herbicide level tested, while in the same study nuclear transformants showed sensitivity when they were treated with Formula XVII at a concentration above 100 nM.

Example 9

Expression of Transgenes in Plastids Using Novel Promoter

[0203] The following invention provides nucleic acid sequences of non-plastid origin useful for the expression of transgenic genes in plastids. There are only a limited number of gene regulatory elements such as promoters, 5′untranslated region (5′UTR) and 3′untranslated region (3′UTR) available for plastid transgene expression and most of them are plastid sequences. As plastid genomes are highly active in homologous recombination, the insertion in the genome of endogeneous sequences as regulatory element could bring about genomic rearrangements resulting in loss or inactivation of the transgenic function. In order to prevent such genomic rearrangement, foreign sequences sharing little homology with plastid genomic DNA sequence should be used as regulatory elements for plastid transgen; expression.

[0204] New Promoter

[0205] The Staphylococcus aureus bacteriophages X2 promoter like-sequence, which was reported to be able to promote gene expression in E. coli. (Carbonelli et al., FEMS Micro. Letters 177:75-82, 1999), was tested for its ability to promote gene expression in tobacco plastids. The X2 sequence (SEQ 10) contains bacteria type promoter features such as canonical hexanucleotide—10 region (TATAAT) and—35 region (TTGCTG) and a—16 promoter box (TRTG), that is also observed in many chloroplast PEP promoters. The X2 sequence (position 141 to 219 from published sequence) was linked to the to a 5′untranslated sequence functional in plastid and fused to a reporter gene in a tobacco plastid transformation vector.

SEQ ID NO:15 Staphylococcus aureus bacteriophage X2 promoter
GTTAAAGAAT GTAGCTGACT GCATACTTAA ACCACCCATA CTAGTTGCTG GGTGGTTTTT 60
ATGTTATAAT ATAAATGTG             79

[0206] New 5′Untranslated Region with Shine-Dalgarno Like Sequence

[0207] In land plant plastids, the mRNA 5′UTR sequences are essential for mRNA stability and translation initiation process. The 5 ′UTRs of most highly expressed plastid genes contain a Shine-Dalgarno like sequence that is complimentary to the 3′end of the plastid 16S rRNA and is believed to play a predominant role in translation initiation. It is possible that foreign sequences that contain a Shine-Dalgarno like sequence might be able to function as plastid gene translation element. The bacteriophage T7 gene 10 5′UTR sequence, which contains a SD element, was previously shown to be very efficient in promoting translation in plastids (McBride et al., (1994) Proc. Natl. Acad. Sci. 91: 7301-7305; Ye et al., (2001) Plant J. 25: 261-270; Kuroda and Maliga (2001) Nucl. Acids Res. 29: 970-975). The following sequence from Kluyvera bacteriophage gene 10 and T3 bacteriophage gene 9 were tested for their ability to act as 5′UTR sequences for plastid gene expression.

SEQ ID NO:16 Kluyvera Bacteriophage kvp1 gene 10 5′UTR
tctagaGACA TTACGTTCTC CCCTTGAGTG ATACACAATG AGAACCAACT CGTTTCAAGT 60
AGTACCTCAC ATAACTTATC TTTTAAATCA ACAGAAGGAG ATTCAcCatg 110
SEQ ID NO:17 Bacteriophage T3 gene 9 5′UTR
tctagAGGGA GACCTCATCT TTGAAATGAG CGATGACTAA AGGTTGGAGT CCTTTGGTTT 60
CCCTTTATCT TTAATAACTT AGGAGATTTA ATtcatg 97

[0208] Making of plastid transformation vector having PPO has selectable marker which is under the control of the bacteriophage X2 promoter

[0209] Amplification of the bacteriophage kvp1 gene 10 5′ UTR

[0210] The kvpI gene 10 5 ′UTR was isolated by PCR amplification from a plasmid containing kvp1 gene 10 using a top strand primer comprising an introduced XbaI restriction site at the 5′end of the 5′UTR region (5′ GTTCTAGAGACATTACGTTCTCCCCTTG 3′ (XbaI site is underline) SEQ ID NO:28) and a bottom strand primer comprising an introduced NcoI restriction site overlapping the ATG initiation codon (5′ AGATATCCATGGTGAATCTCCTGTTGATT 3′ (NcoI restriction site is underline) SEQ ID NO:29). PCR amplification of a 119 bp fragment was performed with taq DNA Polymerase kit (QIAGEN, Valencia Calif.) in a Perkin Elmer Thermal Cycler 480 according to the manufacturer's recommendations (Perkin Elmer/Roche, Branchburg. N.J.) as follows 5 min 95° C., followed by 5 cycles of 1 min 95° C./1 min 40° C./15 sec 72° C., then 25 cycles of 1 min 95° C./1 min 55° C./15 sec 72° C.

[0211] Plasmid pEBPKVP-10 was created by ligating together the 105 bp XbaI-NcoI fragment from the kvp1 gene 10 5′UTR amplified fragment with an 8.0 kb XbaI-NcoI fragment from pEBPaccD vector. Plasmid pEBPKVP10-GFP was created by ligating a 5.2 kb NcoI-BamHI fragment from pEBPKVP10 with a 1.8 Kb fragment from pPB69b, containing green fluorescent protein (GFP) gene linked to the A. thaliana plastid psbA 3 ′UTR. The maize 16S NEP-PEP promoter was amplified by PCR from pPB98 using a top strand primer comprising an introduced EcoRI restriction at the 5′ end of the 16S rRNA gene promoter region (5′ GCCAGAATTCACCACGATCGAACGGGAATGGATA 3′ (EcoRI site is underline)) (SEQ ID NO:20) and a bottom strand primer comprising an introduced XbaI restriction site at the 3′ end of the 16S rRNA gene promoter region (5′ CTCTAGAGATTCGGAATTGTCTTTCCTT 3′ (XbaI restriction site is underline) SEQ ID NO:21). PCR amplification of a 164 bp fragment was performed with the Pfu Turbo DNA polymerase kit (Stratagene, LaJolla Calif.) in a Perkin Elmer Thermal Cycler 480 according to the manufacturer's recommendations (Perkin Elmer/Roche, Branchburg. N.J.) as follows 5 min 95° C., followed by 35 cycles of 1 min 95° C./1 min 50° C./15 sec 72° C.

[0212] The amplified 16S rRNA promoter sequence was cut with XbaI and EcoRI and the resulting 152 bp fragment was ligated to a 6.0 kb XbaI-EcoRI fragment from pB98 plastid transformation vector. The resulting plasmid was subsequently cut with XbaI and BamHI and a 5.1 kb fragment isolated from the digest was ligated with a 1.9 kb XbaI-BamHI fragment from pEBPKVP10-GFP, containing the kvp1 gene 10 5′UTR::GFP ::A.thaliana psbA 3′UTR chimeric, to give pEBZM16SKGFP.

[0213] Construction of Plasmid RTK7 having

[0214] The 116 bp bacteriophage T3 gene 5′UTR was PCR amplified from a plasmid using a top strand primer (RTK36) comprising an introduced NcoI restriction site at the 3′end of the T3 gene 9 5′UTR (5′ GAAGATGCCATGGATTAA -TCTCCT--GTTATTAAAG 3′ (NcoI site is underline) SEQ ID NO:22) and a bottom strand primer (RTK39) comprising an introduced SmaI site at the 5′ end of the 5′UTR (5′ CGAATCTCTTCCCGGGTAGAGGGAGACCTCATCTTTG 3′ (SmaI restriction site is underline)SEQ ID NO:23). A 328 bp fragment having the Maize 16S PEP-NEP rRNA gene promoter and tobacco psbA gene promoter was PCR amplified from pEBT3-9 GFP using a top strand primer (RTK38) comprising an introduced SmaI restriction site at the 3′end of the Maize 16S PEP-NEP promoter (5′ CTCCCTCTACCCGGGAAGAGATTCGGAATTGTCTTTCC 3′ (SmaI site is underline)SEQ ID NO:24) and a bottom strand primer (RTK37) comprising an introduced BspHI site at the 3′ end of the psbA 5′UTR (5′ CGCTTAGTCATGATAAAATCTTGGTTTATTTAATCATC 3′ (BspHI restriction site is underline)SEQ ID NO:25). PCR products were purified, mixed together at equal molar ratio with primers RTK36 and RTK37 and mixture was used to PCR amplify a 421 bp fragment. PCRs were performed with the Pfu Turbo DNA polymerase kit (Stratagene, LaJolla Calif.) in a Perkin Elmer Thermal Cycler 480 according to the manufacturer's recommendations (Perkin Elmer/Roche, Branchburg. N.J.).

[0215] To make plasmid RTK7, the plasmid RTK6 having the ppo and gus genes cloned in opposite orientation was first created by ligating a 7.5 kb HindIII-NcoI fragment from pEB8a, the transformation vector with ppo::N. tabacum rps16 3′UTR chimeric gene, with a 2.1 kb HindIII-NcoI fragment containing gus::A.thaliana psbA 3′UTR gene from plasmid pEBPkvp10. Plasmid RTK7 was eventually made by ligating a NcoI linearized 9.6 kb RTK6 with the 405 bp NcoI-BspHI PCR amplified Maize 16S and psbA promoters. Only the plasmid having psbA promoter driving ppo and Maize 16S PEP-NEP promoter driving gus was retained.

[0216] Construction of a Bacteriophage X2 promoter-like sequence fused to the kvp1 gene 10 5′UTR: GFP::A. thaliana plastid psbA 3′UTR chimeric gene.

[0217] An 85 bp EcoRI-XbaI fragment consisting of the bacteriophage X2 promoter-like sequence was created by annealing together a top stand oligonucleotide (5′ AATTCGTTAAAGAATGTAGCTGACTGCATACTFAAACCACCCATACTAGTTGCTG GGTGGT=TTATGTTATAATATAAATGTGT 3′) (SEQ ID NO:26) with the following complimentary bottom strand oligonucleotide (5′ CTAGACACATTFATATTATAACATAAAAACCACCCAGCAACTAGTATGGGTGGTT TAAGTATGCAGTCAGCTACATTCTTTAACG 3′)(SEQ ID NO:27). Plasmid PEBX2 was created by ligating the created 85 bp EcoRI-XbaI fragment with a 6.8 kb EcoRI-XbaI fragment from pEBZM16SKGFP plasmid, containing the kvp1 gene 10 5′UTR::GFP ::A.thaliana psbA 3′UTR with the remainder of the plastid trnnsformation vector.

[0218] Construction of Plastid Transformation Vector pEB10

[0219] Plasmid pEB9 was created by ligating a 200 bp BglII-NcoI fragment from pEBX2, containing the X2 promoter-like sequence fused to the kvp1 gene 10 5′UTR, and a 8.5 kb BglII-NcoI from pEB8a plastid transformation vector.

[0220] 1 AATTCGTTAA AGAATGTAGC TGACTGCATA CTTAAACCAC CCATACTAGT

[0221] 50 TGCTGGGTGG TTTTTATGTT ATAATATAAA TGTGTCTAGA GACATTACGT

[0222] 100 TCTCCCCTTG AGTGATACAC AATGAGAACC AACTCGTTTC AAGTAGTACC

[0223] 150 TCACATAACT TATC=TTAA ATCAACAGAA GGAGATTCAC Catg

[0224] DNA sequence of the chimeric the Staphylococcus aureus bacteriophages X2 promoter like-sequences fused to the bacteriophage kvp1 gene 10 5′UTR. The X2 sequence is underlined; the initiation codon (ATG) is in small caps. (SEQ ID NO: 18).

[0225] The final pEB10 plastid transformation vector was created by ligating a 7.8 kb BglII-HindIII fragment from pEB9 with a 2.3 kb fragment from pRTK7, containing the chimeric gene pMz16SNEP::T3-9 5′UTR:: uidA:: 3′psbA.

Example 10

Plastid Transformation with pEB10

[0226] Resulting chimeric reporter gene was stably introduced in tobacco plastid genome using plastid transformation dual selection protocol described in U.S. application case 70149. Out of 6 plastes bombed one event was found to be able to grow on 50 nM of butafenacyl after two rounds of selection on spectinomycin. After 3 rounds of selection on butafenacyl the event was confirmed by Southern analysis to be homoplasmic for insertion in the chloroplast genomes of the PPO and gus genes. Activity of GUS was visualized by standard GUS assays.

Claims

1. a method for obtaining a transplastomic plant comprising the steps of: a) introducing into a plant cell plastid a recombinant nucleic acid molecule comprising two distinct selectable marker constructs, wherein the first marker confers resistance to a non-lethal selective compound (non-lethal marker) and the second marker confers tolerance to a lethal compound (lethal marker) and wherein each of the selectable marker constructs comprises a promoter functional in a plant cell plastid and a transcriptional termination region functional in a plant cell plastid b) placing the plant cell comprising the recombinant nucleic acid molecule on a first culture medium comprising a plastid non-lethal compound for either 1) a period of about 2 weeks or 2) or until shoots appear on a callus formed from the plant cell; c) placing the plant cell on a second culture medium comprising a plastid lethal compound for a period of time sufficient to permit the plant cell to be homoplasmic for the transgene.

2. The method of claim 1, further comprising: d) obtaining a transplastomic plant comprising only the second, lethal marker.

3. The method of claim 1, wherein the recombinant nucleic acid molecule further comprises one or more constructs of gene products of interest expressible in plastids are adjacent to the lethal marker.

4. The method of claim 3, wherein the lethal marker and the gene construct or gene constructs have different promoters functional in plastids and are expressed independently.

5. The method of claim 3, wherein the lethal marker and the gene construct or gene constructs are organized as a operon-like polycistronic gene.

6. The method of claim 1, wherein introduction of the recombinant nucleic acid molecule is accomplished by a plastid transformation vector, said vector comprising the recombinant nucleic acid molecule encoding the non-lethal marker in its backbone sequence and the nucleic acid molecule encoding the lethal marker flanked by nucleic acid sequences which are homologous to non-essential plastid nucleic acid sequences.

7. The method of claim 1, wherein introducing the recombinant nucleic acid molecule encoding the markers is accomplished by a plastid transformation vector, said vector comprising the recombinant nucleic acid molecule encoding the non-lethal marker flanked bk nucleic acid sequences which are homologous to essential plastid nucleic acid sequences and the nucleic acid molecule encoding the lethal marker flanked by nucleic acid sequences which are homologous to non-essential plastid nucleic acid sequences.

8. The method of claim 6, wherein the vector is transiently integrated into the plastome.

9. The method of claim 7, wherein the nucleic acid molecule encoding the non-lethal marker is unstably or transiently integrated into the plastome.

10. The method of claim 1, wherein the non-lethal marker is an antibiotic resistance gene.

11. The method of claim 10, wherein the antibiotic resistance gene is aadA and the non-lethal selective compound is spectinomycin or streptomycin.

12. The method of claim 1, wherein the lethal marker is a herbicide tolerance gene.

13. The method of claim 12, wherein the herbicide tolerance gene is a mutated form of a protoporphorynogen oxidase (PPO) and the lethal selective compound is butafenacil or Formula XVII.

14. The method of claim 6, wherein a plastid transformation vector is used comprising SEQ ID NO:1, SEQ ID NO:2 or SEQ ID NO:19.

15. The method of claim 7, wherein a plastid transformation vector comprises SEQ ID NO:3.

16. The method of claim 1, wherein the plant is tobacco, tomato, petunia, potato, brassica spp., safflower, or lemna.

17. A plastid transformation vector comprising a non-lethal marker in the backbone sequence of the vector and a lethal marker flanked by sequences which are homologous to non-essential plastid DNA sequences.

18. A plastid transformation vector comprising a non-lethal marker in the backbone sequence of the vector and a lethal marker adjacent to one or more constructs of gene products of interest expressible in plastids flanked by sequences which are homologous to non-essential plastid DNA sequences.

19. The plastid transformation vector of claim 18, wherein the lethal marker and the gene construct or gene constructs have different promoters functional in plastids and are expressed independently.

20. The plastid transformation vector of claim 18, wherein the lethal marker and the gene construct or gene constructs are organized as a operon-like polycistronic gene.

21. The plastid transformation vector of claim 17 comprising SEQ ID NO:1.

22. The plastid transformation vector of claim 19 comprising SEQ ID NO:2.

23. The plastid transformation vector of claim 19 comprising SEQ ID NO:19.

24. A plastid transformation vector comprising a non-lethal marker flanked by sequences homologous to essential plastid DNA sequences but no non-lethal marker flanked by DNA sequences homologous to non-essential plastid DNA sequences.

25. The plastid transformation vector according to claim 24 comprising SEQ ID NO:3.

26. The plastid transformation vector of claim 24, further comprising a lethal marker adjacent to one or more constructs of gene products of interest expressible in plastids flanked by sequences which are homologous to non-essential plastid DNA sequences.

27. The plastid transformation vector of claim 25, wherein the lethal marker and the gene construct or constructs have different promoters functional in plastids and are expressed independently.

28. The plastid transformation vector of claim 24, wherein the lethal marker and the gene construct or gene constructs of interest are organized as an operon-like polycistronic gene.

29. A method for obtaining a chloroplast transformed algae comprising the steps of: a) introducing into a plastid of a an algae a recombinant nucleic acid molecule encoding at least two distinct selectable markers expressible in plastids, wherein the first marker confers resistance to a non-lethal selective compound (non-lethal marker) and the second marker is conferring tolerance to a lethal compound (lethal marker) and wherein; b) a first round of selection using the non-lethal selective compound alone or in combination with the lethal selective compound for selection of a transformed plastid; and c) a second round of selection using the lethal compound as the sole selective compound such that the non-lethal marker gene is removed from the plastome.

30. The method of claim 29 wherein the algae is a Chlamydamonas spp., a red algae or a green algae.

31. A method of obtaining a transplastomic plant comprising the steps of: a) introducing into a plant cell plastid a recombinant nucleic acid molecule comprising two distinct selectable marker constructs, wherein the first marker confers resistance to a non-lethal selective compound (non-lethal marker) and the second marker confers tolerance to a lethal compound (lethal marker) and wherein each of the selectable marker constructs comprises a promoter functional in a plant cell plastid and a transcriptional termination region functional in a plant cell plastid b) placing the plant cell comprising the recombinant nucleic acid molecule on a first culture medium comprising a plastid non-lethal compound and a lethal compound for 1) a period of about 2 weeks or 2) until shoots appear on a callus formed from the plant cell; c) placing the plant cell on a second culture medium comprising a plastid lethal compound for a period of time sufficient to permit the plant cell to be homoplasmic for the transgene.

32. The method of claim 31, wherein the lethal compound is a herbicide and the non-lethal compound is an antibiotic.

33. The method of claim 32, wherein the lethal compound is butafenacil or Formula XVII and the antibiotic is spectinomycin or streptomycin.

34. The method of claim 33, wherein the concentration of the lethal compound is less than about 10 nM.

35. The method of claim 33, wherein the concentration of the lethal compound is between about 5 nM and about 25 nM.

36. The method of claim 33, wherein the concentration of the lethal compound is between about 25 nM and about 50 nM.